PDS Biotechnology Corp.
Key Metrics
Market Snapshot
About
PDS Biotechnology is a clinical-stage immuno-oncology company developing therapies for cancer and infectious diseases. The company uses its proprietary Versamune T-cell activating platform to create cancer vaccines and immunotherapies. Lead programs target HPV-associated cancers and other solid tumors by activating immune responses against tumor-specific antigens.